FDX.US Weekly Report · 2026-W37
FDX declined 3.27% to $311.99 this week, with latest earnings showing 12.54% revenue growth overshadowed by a 3.1% year-over-year profit decline, underscoring margin compression. Net capital inflows lack institutional participation, while analyst targets embed 13.8% upside but appear lagged; near-term weakness reflects macro uncertainty overpowering fundamental support.
Weekly Trading
FDX fell $10.53 (3.27%) from last week’s close of $322.52 on September 4, finishing at $311.99. Intra-week range: $315.44 high to $306.79 low, a 4.5% swing. Weekly volume totaled 5.24 million shares (daily average ~1.31 million) with a 0.55% turnover rate, in line with 60-day averages—no extraordinary activity. The weekly pattern shows continuous downward pressure with minimal recovery, reflecting sustained weakness.
Valuation & Earnings
Valuation: P/E of 16.68x sits at approximately the 18.7th percentile of a 5-year range, indicating relative cheapness. Against an industry median P/E of 3.86x, FDX trades at a significant premium, reflecting quality recognition without absolute overvaluation. P/B of 2.33x is reasonable-to-low.
Earnings: Q4 2026 EPS of $6.62 declined 4.3% YoY; revenue of $250.07B grew 12.54% YoY; net profit of $1.595B fell 3.1% YoY. QoQ, Q4 profit recovered from Q3, but the net margin (6.39%) compressed versus Q4 2025 (7.42%). Diverging revenue growth and profit decline signal rising costs, pressuring earnings quality.
Capital & Institutions
Capital Flows: As of September 11: large cap inflow 111.13, mid-tier 144.82, retail 698.27 units. Overall net inflow is retail-driven; institutional players notably absent, signaling cautious professional positioning against retail optimism but with limited conviction.
Analyst Coverage: Among 28 analysts, 16 buy, 4 outperform, 6 hold, 1 underperform, 1 sell. Consensus price target: $355.10, implying 13.8% upside. Latest update: September 9, 2026. Note: analyst ratings lag market repricing; the week’s decline may not yet be fully reflected.
Summary
Macro headwinds (PPI inflation, FOMC uncertainty) dominate near-term direction, outweighing valuation cheapness and fundamentals. The disconnect between analyst optimism and recent price action, combined with institutional caution, suggests a consolidation phase ahead. Profit decline remains the key overhang; clarity depends on forward earnings trends.